Chlorophyllin (CHL), a water-soluble salt of chlorophyll, is a blocking agent against 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), and when given post-initiation suppressed IQ-induced rat liver tumors. Paradoxically, at low doses, CHL promoted colon tumorigenesis induced by IQ and 1,2-dimethylhydrazine (DMH) in the rat, but suppressed at higher doses. Recent human trials have raised high hopes for protection by CHL against liver cancer, but there is a need to better define risk versus benefit for CHL against colon cancer, a major cause of US cancer deaths.
Aim 1. PROMOTION IN VIVO - Test for tumor promotion by CHL, chlorophyll, Cu and phytol in the rat; examine expression levels and cellular localization of beta-catenin and E-cadherin in tumors. 1A. Using a dose of CHL that promoted colon tumors in prior studies, test equivalent doses of chlorophyll, copper and phytol in full-length tumor bioassays, with IQ and DMH as initiating agents. 1B. Determine the spectrum and frequency of beta-catenin mutations during colon tumor promotion. 1C. Examine the expression of beta-catenin and downstream targets during colon tumor promotion. 1D. Study E-cadherin expression and sub-cellular localization during colon tumor promotion.
Aim 2. SUPPRESSION IN VIVO - Test for tumor suppression using a CHL dose shown previously to augment apoptosis and cell proliferation in the rat colon, and examine beta-catenin expression. 2A. Demonstrate suppression of DMH- and IQ-induced colon tumors by high dose CHL. 2B. Determine the spectrum and frequency of beta-catenin mutations during colon tumor suppression. 2C. Examine the expression of beta-catenin and downstream targets during colon tumor suppression. 2D. Study beta-catenin/E-cadherin expression and co-localization during colon tumor suppression.
Aim 3. MECHANISMS OF PROMOTION AND SUPPRESSION - Study the effects of CHL on the duality of beta-catenin function: signaling versus cell-cell adhesion 3A. Determine the extent to which CHL alters the expression of beta-catenin transcript. 3B. Examine the phosphorylation, ubiquitination, and proteosomal degradation of beta-catenin. 3C. Determine CHL effects on beta-catenin nuclear export and Adherins junction remodeling. 3D. Assess direct effects of CHL on a downstream target of beta-catenin, c-Jun.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA065525-09
Application #
7217931
Study Section
Special Emphasis Panel (ZRG1-CDP (01))
Program Officer
Davis, Cindy D
Project Start
1996-03-15
Project End
2009-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
9
Fiscal Year
2007
Total Cost
$298,627
Indirect Cost
Name
Oregon State University
Department
Type
Organized Research Units
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Beaver, Laura M; Kuintzle, Rachael; Buchanan, Alex et al. (2017) Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer. J Nutr Biochem 42:72-83
Johnson, Gavin S; Li, Jia; Beaver, Laura M et al. (2017) A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells. Mol Nutr Food Res 61:
Ertem, Furkan; Dashwood, Wan-Mohaiza; Rajendran, Praveen et al. (2016) Development of a murine colonoscopic polypectomy model (with videos). Gastrointest Endosc 83:1272-6
Kim, Eunah; Bisson, William H; Löhr, Christiane V et al. (2016) Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors. Curr Top Med Chem 16:714-31
Wong, Carmen P; Hsu, Anna; Buchanan, Alex et al. (2014) Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells. PLoS One 9:e86787
Beaver, Laura M; Buchanan, Alex; Sokolowski, Elizabeth I et al. (2014) Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention. Mol Nutr Food Res 58:2001-13
Rajendran, Praveen; Kidane, Ariam I; Yu, Tian-Wei et al. (2013) HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. Epigenetics 8:612-23
Wang, Rong; Löhr, Christiane V; Fischer, Kay et al. (2013) Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer. Int J Cancer 132:1004-12
W Watson, Gregory; M Beaver, Laura; E Williams, David et al. (2013) Phytochemicals from cruciferous vegetables, epigenetics, and prostate cancer prevention. AAPS J 15:951-61
Beaver, Laura M; Yu, Tian-Wei; Sokolowski, Elizabeth I et al. (2012) 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol Appl Pharmacol 263:345-51

Showing the most recent 10 out of 66 publications